Idexx Laboratories Inc
IDXX Real Time Price USDRecent trades of IDXX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IDXX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
IDXX Revenue by Segment or Geography
New patents grants
-
Patent Title: Display screen or portion thereof with graphical user interface for viewing x-ray images and calculating vertebral heart score Apr. 01, 2025
-
Patent Title: Markers for renal disease Mar. 04, 2025
-
Patent Title: Rocky mountain spotted fever detection and treatment Feb. 18, 2025
-
Patent Title: Collection device and method Feb. 18, 2025
-
Patent Title: Systems and methods of digital tracking of wellness programs Feb. 04, 2025
-
Patent Title: Flow cytometer and laser optics assembly thereof Jan. 21, 2025
-
Patent Title: Systems, devices, and methods for managing operation of diagnostic testing instruments Jan. 14, 2025
-
Patent Title: Methods and systems for x-ray imaging and labeling Jan. 07, 2025
-
Patent Title: Z-axis measurement fixture and method of determining the planarity of objects using the fixture Dec. 31, 2024
-
Patent Title: Systems and methods for modulating sensitivity of a photometer Jul. 30, 2024
-
Patent Title: Devices and methods facilitating sample testing Jul. 16, 2024
-
Patent Title: Methods for measuring bacteria in biological samples Jul. 09, 2024
-
Patent Title: Methods and systems for in-clinic compliance protocols Jul. 02, 2024
-
Patent Title: System and method for retrieving data from a non-networked, remotely-located data generating device Jun. 04, 2024
-
Patent Title: Point-of-care medical diagnostic analyzer and devices, systems, and methods for medical diagnostic analysis of samples May. 07, 2024
-
Patent Title: Animal cage-sample collection apparatus May. 07, 2024
-
Patent Title: Markers for renal disease Mar. 19, 2024
-
Patent Title: Methods and systems for x-ray imaging and labeling Mar. 05, 2024
-
Patent Title: Homogenous immunoassay with compensation for background signal Feb. 27, 2024
-
Patent Title: Multi-well sample testing apparatus and methods of sample testing using the same Feb. 20, 2024
-
Patent Title: Methods for determining the density of polymer particles for quality control materials using split flow thin (splitt) cell fractionation principle and fractionation cell for carrying out the methods Feb. 13, 2024
-
Patent Title: Quality control for point-of-care diagnostic systems Jan. 30, 2024
-
Patent Title: Flow cytometer and laser optics assembly thereof Jan. 23, 2024
-
Patent Title: Z-axis measurement fixture and method of determining the planarity of objects using the fixture Dec. 05, 2023
-
Patent Title: Lateral flow assay reader based on human perception and method relating thereto Oct. 17, 2023
-
Patent Title: Nucleic acid amplification controls and kits and methods of use thereof Aug. 15, 2023
-
Patent Title: Hematology test slide Jun. 06, 2023
-
Patent Title: Flow cytometer, laser optics assembly thereof, and methods of assembling the same May. 30, 2023
-
Patent Title: Multi-well sample testing apparatus and methods of sample testing using the same Apr. 04, 2023
-
Patent Title: Method and system for representation of current and historical medical data Jan. 10, 2023
-
Patent Title: Flow cytometer and laser optics assembly thereof Jan. 03, 2023
-
Patent Title: Point-of-care diagnostic systems and containers for same Jan. 03, 2023
-
Patent Title: Methods for measuring analyte and/or protein in biological samples Dec. 20, 2022
-
Patent Title: Quality control for point-of-care diagnostic systems Sep. 13, 2022
-
Patent Title: Markers for renal disease Sep. 06, 2022
-
Patent Title: Detection of symmetrical dimethylarginine Aug. 23, 2022
-
Patent Title: Point-of-care diagnostic systems and containers for same Jun. 14, 2022
-
Patent Title: Compositions, devices, kits and methods for detecting hookworm Mar. 08, 2022
-
Patent Title: Hematology test slide Oct. 12, 2021
-
Patent Title: Sealed lateral flow device Sep. 28, 2021
-
Patent Title: Immunoassay test slide Jun. 29, 2021
-
Patent Title: Methods for detecting renal disease Jun. 15, 2021
-
Patent Title: Methods, devices, kits and compositions for detecting tapeworm May. 11, 2021
-
Patent Title: Methods, devices, kits and compositions for detecting roundworm, whipworm and hookworm Mar. 09, 2021
-
Patent Title: Flow cytometer, laser optics assembly thereof, and methods of assembling the same Feb. 09, 2021
-
Patent Title: Method and device for detecting bacteria and determining the concentration thereof in a liquid sample Feb. 09, 2021
-
Patent Title: Lateral flow assay reader based on human perception and method relating thereto Dec. 01, 2020
-
Patent Title: Homogenous immunoassay with compensation for background signal Sep. 15, 2020
-
Patent Title: Methods and compositions for the detection and diagnosis of renal disease and periodontal disease Jul. 28, 2020
-
Patent Title: Compositions, devices, kits and methods for detecting hookworm May. 05, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to IDXX
Recent picks made for IDXX stock on CNBC
ETFs with the largest estimated holdings in IDXX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $IDXX stock a Buy, Sell, or Hold?
- What is the price target for $IDXX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $IDXX stock?
- Who owns the most shares of $IDXX stock?
- What funds own $IDXX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IDXX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.